NuCana (NCNA) Goodwill & Intangibles (2016 - 2025)
NuCana's (NCNA) quarterly Goodwill & Intangibles came in at $2.9 million in Q4 2025, up 3.59% year-on-year from $2.8 million in Q4 2024, and down 1.38% quarter-over-quarter from $3.0 million in Q3 2025.
NuCana (NCNA) Goodwill & Intangibles (2016 - 2025) Analysis & Trends
NuCana has disclosed Goodwill & Intangibles across 10 years of filings, most recently posting $2.9 million for Q4 2025.
- Goodwill & Intangibles for Q4 2025 came in at $2.9 million, up 3.59% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.9 million (up 3.59% YoY), and the FY2025 annual result was $2.9 million, up 3.1% from the prior year.
- Goodwill & Intangibles came in at $2.9 million for Q4 2025 at NuCana, down from $3.0 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $8.7 million in Q4 2022 to a low of -$6.0 million in Q4 2021.
- The 5-year median for Goodwill & Intangibles is $3.0 million (2022), against an average of $3.2 million.
- Across the five-year window, Goodwill & Intangibles tumbled 1905.15% in 2021 and jumped 1616.02% in 2024, its largest moves.
- NuCana's Goodwill & Intangibles stood at -$6.0 million in 2021, then jumped by 245.86% to $8.7 million in 2022, then slumped by 102.13% to -$186172.8 in 2023, then surged by 1616.02% to $2.8 million in 2024, then gained by 3.59% to $2.9 million in 2025.
- The last three Goodwill & Intangibles figures came in at $2.9 million (Q4 2025), $3.0 million (Q3 2025), and $2.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.92 Mn |
| Sep 30, 2025 | 2.96 Mn |
| Jun 30, 2025 | 2.93 Mn |
| Mar 31, 2025 | 2.76 Mn |
| Dec 31, 2024 | 2.82 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 2.79 Mn |
| Mar 31, 2024 | 2.75 Mn |
| Dec 31, 2023 | -186,172.78 |
| Sep 30, 2023 | 3.27 Mn |
| Jun 30, 2023 | 3.19 Mn |
| Mar 31, 2023 | 3.01 Mn |
| Dec 31, 2022 | 8.73 Mn |
| Sep 30, 2022 | 2.96 Mn |
| Jun 30, 2022 | 3.11 Mn |
| Mar 31, 2022 | 3.36 Mn |
| Dec 31, 2021 | -5.98 Mn |
| Sep 30, 2021 | 6.75 Mn |
| Jun 30, 2021 | 6.73 Mn |
| Mar 31, 2021 | 6.57 Mn |